New and Emerging Treatment Options for Hematological Malignancies – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve the care of patients with hematological malignancies by accelerating the adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options, particularly multiple myeloma (MM), Hodgkin’s lymphoma (HL), and diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML).

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists, nurse practitioners, physician assistants, and nurses involved in caring for and treating patients with hematological malignancies.

Commercial Supporter

---

This activity is supported by an educational grant from Pfizer.